BIOGEN for BIOGEN
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Transportation TRA
General discussions regarding disability provisions in FAA Reauthorization legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing The Mental Health Professionals Workforce Shortage Loan Repayment Act S.1214, RARE Act Issues related to ALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| JOHN RAYMOND GIBSON | — |
| TYLER HANSON | — |
| DANIEL HARDER | — |
| ALI LAKHANI | — |
Medicare/Medicaid MMM
Drug cost and pricing policy issues Issues related to the 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
Pharmacy PHA
Drug cost and pricing policy S.1967, PBM Act S.1542, DRUG Act H.R.5539, ORPHAN Cures Act Education and discussions regarding pharmaceutical issues related to supply chain H.R.830, HELP Copays Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON NICHOLAS BADIDA | — |
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) Issues related to OECD negotiations on the taxation of global income
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Trade (domestic/foreign) TRD
Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Copyright/Patent/Trademark CPT
Support stronger IP and exclusivity protections and enforcement in foreign markets
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.